[
  {
    "ts": null,
    "headline": "Is Moderna (MRNA) Pricing Reflecting Potential After Sharp Multi‑Year Share Price Pullback?",
    "summary": "If you are wondering whether Moderna's current share price reflects its true potential, or if the market is still anchored to its pandemic story, this article will help you unpack what the numbers may indicate about value. At a last close of US$42.23, Moderna's stock shows a 3.0% return over 7 days, 1.0% over 30 days, 36.8% year to date and 28.0% over 1 year, set against a 74.7% decline over 3 years and a 75.8% decline over 5 years. Recent news about Moderna has focused on its position in...",
    "url": "https://finnhub.io/api/news?id=bd732a7ee5e88660169aea2ed166d15109a2fc80bc4a5f79eabfc60ea038790f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771189718,
      "headline": "Is Moderna (MRNA) Pricing Reflecting Potential After Sharp Multi‑Year Share Price Pullback?",
      "id": 139108330,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "If you are wondering whether Moderna's current share price reflects its true potential, or if the market is still anchored to its pandemic story, this article will help you unpack what the numbers may indicate about value. At a last close of US$42.23, Moderna's stock shows a 3.0% return over 7 days, 1.0% over 30 days, 36.8% year to date and 28.0% over 1 year, set against a 74.7% decline over 3 years and a 75.8% decline over 5 years. Recent news about Moderna has focused on its position in...",
      "url": "https://finnhub.io/api/news?id=bd732a7ee5e88660169aea2ed166d15109a2fc80bc4a5f79eabfc60ea038790f"
    }
  }
]